Raloxifene A Selective Estrogen Receptor Modulator - American.
Sep 15, 1999. The long-term clinical benefits of raloxifene therapy in preventing bone loss must be firmly established. In addition to demonstrating safety and. Mar 21, 2001. Evista may be the estrogen substitute that has all the advantages of estrogen but none of the risks, says Elizabeth Barrett-Connor, MD, who. Evista raloxifene a drug prescribed for the prevention and treatment of osteoporosis. Side effects may include bronchitis, vomiting, insomnia, breast pain, and.
SERMs for Osteoporosis Raloxifene Evista - WebMD
Sep 23, 2017. Raloxifene Evista belongs to a class of drugs called selective estrogen. SERMs were developed to reap the benefits of estrogen while. Jun 8, 2015. Benefits of Evista. The large STAR Study of Tamoxifen and Raloxifene trial compared Evista and tamoxifen, another SERM, to see if one.